Form 4: Glen Taylor Reports Changes in Beneficial Ownership of Envoy Medical, Inc. (COCH)

Glen Taylor, a director and 10% owner of Envoy Medical, Inc., filed a Form 4 detailing changes in his beneficial ownership, including the acquisition of warrants and holdings through related entities.

Summary

• Glen Taylor, a director and 10% owner of Envoy Medical, Inc. (COCH), reported changes in beneficial ownership.
• The report includes direct ownership of 2,953,607 shares of Class A Common Stock.
• Taylor also has indirect ownership through Taylor Sports Group (2,526,058 shares) and GAT Funding, LLC (4,810,384 shares).
• A warrant to purchase 250,000 shares of Class A Common Stock at $2.25 was acquired on July 22, 2024, as a commitment fee related to a promissory note draw.
• Other warrants held indirectly through GAT Funding, LLC include rights to buy 500,000 shares at $1.24 and 250,000 shares at $3.04.
• Taylor's indirect holdings include 1,000,000 shares of Class A Common Stock underlying Series A Preferred Stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the document is a standard SEC filing reporting changes in ownership. The acquisition of warrants could be seen as a slightly positive sign.

Positives

• The filing provides transparency into the holdings of a major shareholder and director.
• The acquisition of warrants suggests continued investment in the company's future.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders.

Related Party Transactions

• The warrant issued to GAT Funding, LLC is related to a promissory note draw, indicating a financial relationship between the company and an entity controlled by Glen Taylor.

Stakeholder Impact

• The filing provides shareholders with information about insider transactions, which can influence investor confidence.

Key Dates